Can-Fite BioPharma CANF
NYSE CANF
$2.24 +0.04 (+1.82%)
As of: Oct 1, 2026 · 3:59 PM EDT

Can-Fite BioPharma (CANF) Long-Term Investments (2014 - 2018)

Updated

Can-Fite BioPharma's Long-Term Investments came in at $2,000 for Q4 2018, down 99.8% from $917,000 a year earlier and down 99.8% from the prior quarter.

Analysis

Can-Fite BioPharma (CANF) Long-Term Investments (2014 - 2018) Analysis & Trends

Going back to Q1 2014, Can-Fite BioPharma's Long-Term Investments data covers 7 quarters.

  • Going back by year, Long-Term Investments was $917,000 in FY2017 and $10,000 in FY2016.
  • Business Quant data shows CANF's Long-Term Investments at $1.08 million (Q3 2018), $1.83 million (Q2 2018) and $927,000 (Q1 2018) in the three quarters before Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Can-Fite BioPharma 1.82 Mn -17.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 2,000.00
Sep 30, 2018 1.08 Mn
Jun 30, 2018 1.83 Mn
Mar 31, 2018 927,000.00
Dec 31, 2017 917,000.00
Dec 31, 2016 10,000.00
Mar 31, 2014 12,000.00
API Access

Can-Fite BioPharma Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=CANF&period=max&api_key=YOUR_API_KEY